UNIGE document Scientific Article
previous document  unige:25125  next document
add to browser collection
Title

Efficacy, tolerability and risk factors for virological failure of darunavir-based therapy for treatment-experienced HIV-infected patients: the Swiss HIV Cohort Study

Authors
Young, J
Günthard, H F
Opravil, M
Yerly, S
Böni, J
Rickenbach, M
Fux, C A
show hidden authors show all authors [1 - 14]
Published in HIV Medicine. 2011, vol. 12, no. 5, p. 299-307
Abstract Darunavir was designed for activity against HIV resistant to other protease inhibitors (PIs). We assessed the efficacy, tolerability and risk factors for virological failure of darunavir for treatment-experienced patients seen in clinical practice.
Keywords Bayes TheoremCD4 Lymphocyte CountCohort StudiesDrug Resistance, ViralFemaleHIV Infections/drug therapy/immunologyHIV Protease Inhibitors/therapeutic useHIV-1/drug effectsHumansMaleMiddle AgedProspective StudiesRisk FactorsSalvage TherapySulfonamides/therapeutic useTreatment OutcomeViral Load
Identifiers
PMID: 20955357
Full text
Article (Published version) (96 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Research groups Groupe Laurent Kaiser (virologie clinique) (668)
Unité HIV (46)
Citation
(ISO format)
YOUNG, J et al. Efficacy, tolerability and risk factors for virological failure of darunavir-based therapy for treatment-experienced HIV-infected patients: the Swiss HIV Cohort Study. In: HIV Medicine, 2011, vol. 12, n° 5, p. 299-307. https://archive-ouverte.unige.ch/unige:25125

178 hits

0 download

Update

Deposited on : 2013-01-08

Export document
Format :
Citation style :